1. Home
  2. CRCT vs FTRE Comparison

CRCT vs FTRE Comparison

Compare CRCT & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cricut Inc.

CRCT

Cricut Inc.

HOLD

Current Price

$4.24

Market Cap

857.6M

Sector

Industrials

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$9.59

Market Cap

829.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRCT
FTRE
Founded
1969
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
857.6M
829.3M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
CRCT
FTRE
Price
$4.24
$9.59
Analyst Decision
Strong Sell
Buy
Analyst Count
2
9
Target Price
$3.50
$14.17
AVG Volume (30 Days)
484.4K
978.7K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
22.25%
N/A
EPS Growth
20.69
N/A
EPS
0.35
N/A
Revenue
$708,780,000.00
$2,723,400,000.00
Revenue This Year
$0.08
N/A
Revenue Next Year
$0.98
$3.01
P/E Ratio
$12.20
N/A
Revenue Growth
N/A
1.00
52 Week Low
$3.74
$3.97
52 Week High
$7.33
$18.67

Technical Indicators

Market Signals
Indicator
CRCT
FTRE
Relative Strength Index (RSI) 56.14 46.40
Support Level $4.20 $8.80
Resistance Level $4.26 $11.22
Average True Range (ATR) 0.14 0.66
MACD 0.05 0.13
Stochastic Oscillator 82.40 52.17

Price Performance

Historical Comparison
CRCT
FTRE

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: